Lantern Pharma Inc. Common Stock (NASDAQ: LTRN) last traded at $0.813, down 2.05% on the session. The quote above updates while this page is open; the figures below are drawn from Lantern Pharma Inc. Common Stock’s own filings and are restated only when a new one is published.
Lantern Pharma Inc. Common Stock trades on NASDAQ under the ticker LTRN. Its market capitalisation is $10.39 million.
Valuation measures for Lantern Pharma Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.39M |
|---|---|
| Enterprise value | $15.55M |
| Beta | 2.71 |
Trailing-twelve-month figures tagged in Lantern Pharma Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$18.65M |
|---|---|
| EPS (TTM) |
| -$1.62 |
| Cash | $6.66M |
|---|
Range and volume for LTRN over the past 52 weeks.
| 52-week high | $4.58 |
|---|---|
| 52-week low | $0.760 |
| Volume | 274.9K |
| Average volume | 181.9K |
| Previous close | $0.830 |
Invest a chosen dollar amount in Lantern Pharma Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LTRN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.